Elite Pharmaceuticals, Inc.
ELTP
Get informed when a big investor buys or sells
+ FollowMarket Cap$398.53M
Close$
$0.26
29.5% downside
Current Fair Value
29.5% downsideOvervalued by 29.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $398.53 Million |
|---|---|
| Enterprise Value | $-28,385,711,299.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.38 |
| Outstanding Shares | 1,074,745,442 |
Return
| Return on Equity | 45.38% |
|---|---|
| Return on Assets | 0.03% |
| Return on Invested Capital | 0.03% |
Valuation & Multiples
| P/E Ratio | 9.49 |
|---|---|
| PEG | 110.19 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -190.67 |
| Enterprise Value to EBIT | -801.53 |
| Enterprise Value to Net Income | -633 |
| Total Debt to Enterprise | -0.04 |
| Debt to Equity | 10.25 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $180▼ 26.53% |
| Investors Holding | 10% |
ESG Score
No data